at Nasdaq.com (Mon, 4:30PM)
Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street consensus at its Analyst Day earlier this morning. The company now expects earn around $0.35 per share on revenue of $41M to $44M, below analysts estimates of $0.43 on $45M. (Webcast replay)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Dec 29, 2014)
at Zacks.com (Nov 13, 2014)
at Zacks.com (Oct 29, 2014)
at MarketWatch.com (Oct 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs